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 Case Report/Relato de Caso
INTRODUCTION
CASE REPORT
Mediastinitis and pericardial effusion in a patient with AIDS and 
disseminated Mycobacterium avium infection:  a case report
Mediastinite e derrame pericárdico em um paciente com AIDS e infecção disseminada por 
Mycobacterium avium: um relato de caso
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ABSTRACT
We report the case of a 36-year-old man who had acquired immune deficiency 
syndrome and developed suppurative mediastinitis extending over the left 
lung and anterior thoracic wall around the sternum, pericardial effusions, 
splenomegaly, and mesenteric and periaortic lymphadenomegaly due to 
Mycobacterium avium (genotype I). The organism was isolated from an 
axillary lymph node and the bone marrow. Mediastinitis associated with 
disseminated M. avium complex infection is uncommon and, to the best of 
our knowledge, this manifestation has not reported before.
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RESUMO
Relatamos o caso de um paciente de 36 anos vivendo com AIDS que desenvolveu 
mediastinite supurativa com extensão ao pulmão esquerdo e à parede 
anterior do tórax ao redor do esterno, derrame pericárdico, esplenomegalia 
e adenomegalia mesentérica e periaórtica, devido ao Mycobacterium avium 
genótipo I, isolado de linfonodo axilar e da medula óssea. A mediastinite 
associada à infecção pelo Mycobacterium avium é rara e, até onde conhecemos 
na literatura publicada, esta forma de apresentação ainda no foi relatada.
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HIV.
Mycobacteria are ubiquitous and important agents of 
opportunistic infections in patients with human immunodeficiency 
virus (HIV)/acquired immuno deficiency syndrome (AIDS). 
Non-tuberculous mycobacteria can produce severe disease such as 
disseminated disease. They have been recovered from surface and tap 
water, soil, domesticated and wild animals, milk, and food products1. 
They are not communicable from person to person and are often 
strikingly resistant to most available drugs. The Mycobacterium avium 
complex (MAC) involves the most common atypical mycobacteria 
to cause disease in HIV/AIDS patients with a low T-lymphocyte 
CD4+ count2,3. Mediastinitis and pericardial effusion in disseminated 
Mycobacterium avium complex (DMAC) infections are uncommon 
clinical features and, as far as we know from the published literature, 
this manifestation has not been reported previously. The patient’s 
identity was protected by excluding all personal data from this report, 
with the exception of age and sex data, and deleting his personal 
identification details from the radiological examination results, in 
agreement with the ethical principles for this kind of case report. All 
of the authors declare no conflicts of interest related to any matter 
associated with the present case report.
A 36-year-old male with AIDS presented with 2 moderately 
swollen areas, i.e., in the suprasternal notch and the middle sternum 
area; mild odynophagia; fever; and weight loss of 1-month duration. 
Other symptoms included mild diarrhea, dyspnea, and decreased 
energy in the right upper and left lower limbs for the previous 
2 months. Physical examination demonstrated tachypnea; pale 
mucosa; crackles on the base of the left lung; 2 painless and swollen 
areas with soft consistency, without erythema or heat; dullness of 
Traube’s space; and right hemiparesis. The tuberculin skin test was 
non-reactive. A thoracic X-ray showed a chronic inflammatory lesion 
in the upper lobe of the left lung and moderate cardiac enlargement. 
Doppler echocardiography revealed a moderate pericardial effusion 
without cardiac tamponade or diastolic dysfunction. Chest computed 
tomography (CT) identified suppurative mediastinitis extending 
over the left lung and anterior thoracic wall, surrounding the sternum 
(Figure 1A, B, C, and D). Abdominal CT showed hepatomegaly 
and splenomegaly, with a 6-mm hypodense area. Mesenteric and 
periaortic lymphadenomegaly were also observed. Three cerebral 
white matter lesions localized in the right frontal, left parietal, 
and occipital lobes were detected on the axial T2 and T2 fluid 
attenuated inversion recovery-weighted magnetic resonance imaging 
(MRI) sequences; the post-contrast images demonstrated the 
ring-enhancing sign and surrounding vasogenic edema, suggesting 
toxoplasmic encephalitis. Laboratory tests showed negative sputum 
results for acid-fast bacilli and the following results: hemoglobin, 
6.3g/dL; leukocytes, 5,400 cells/µL; platelets, 107,000 cells/µL; 
erythrocyte sedimentation rate, 85mm/h; and alkaline phosphatase, 
854IU/L. The T-lymphocyte cell counts were as follows: CD4+, 12 
cells/µL; CD8+, 115 cells/µL (CD4/CD8 = 0.10); the viral HIV load 
was above the superior limit of detection (>500,000 copies/µL). The 
results for anti-Toxoplasma immunoglobin G (IgG) antibody were 
positive and those for IgM were negative. Cultures from peripheral 
blood, aspirates of purulent material from one of the swollen masses, 
and bronchoalveolar lavage samples were negative for pyogenic 
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FIGURE 1 – Contrast-enhanced chest and abdominal computed tomography 
images. A, B, C, and D: Mediastinitis and chest wall abscess (red arrows) at the 
time of diagnosis. E and F: At 3 weeks before the patient’s death, generalized 
abdominal lymph node enlargement (red arrows) was seen, and some of the 
lymph nodes had a diameter of 4 cm; significant splenomegaly was also seen.
A                                                                      B
C                                                                      D
E                                                                      F
bacteria, fungi, and mycobacteria. An axillary lymph node biopsy was 
performed, and the histopathology showed a diffuse granulomatous 
infiltrate with abundant acid-fast bacilli. One month later, the PCR-
restriction enzyme analysis (PRA) method identified M. avium 
(genotype I) from an axillary lymph node biopsy and positive bone 
marrow aspiration cultures. Antimicrobial sensitivity testing was 
not performed.
Antiretroviral treatment was started with lamivudine, stavudine, 
and efavirenz. Sulfadiazine and pyrimethamine plus folinic acid were 
used against toxoplasmic encephalitis. Anti-tuberculous therapy was 
initiated with rifampin, isoniazid, and pyrazinamide after the initial 
histopathology findings. The patient developed toxic hepatitis with 
jaundice (total bilirubin: 7.62mg/dL; direct bilirubin: 5.2mg/dL; 
aspartate aminotransferase: 207IU/L; and alanine aminotransferase: 
308IU/L). Therefore, overall therapy was suspended. Three weeks 
later, serum liver enzymes and bilirubin returned to baseline levels. 
At that time point, M. avium was identified and clarithromycin plus 
ethambutol and anti-retroviral and anti-Toxoplasma therapies were 
reintroduced. His neurological deficit improved with a significant 
reduction in cerebral lesions, as demonstrated in the MRI control 
image obtained in the sixth week of treatment. For the next 6 months, 
the patient improved with complete resolution of mediastinitis and 
pericardial effusion. No further invasive procedures were performed 
to confirm the etiology of the pericardial effusion. After this initial 
period, the patient began to lose weight; then, he underwent a 
medullar aspirate that revealed abundant acid-fast bacilli. Severe 
bowel obstruction with moderate ascites was observed 2 months 
later due to generalized abdominal lymph node enlargement 
(Figure 1E and F). Ciprofloxacin (500mg q12h) was added to the 
current therapy, obtaining mild clinical improvement. After 3 weeks, 
the patient died from multiple organ failure syndrome.
DMAC infection in HIV/AIDS-patients could involve 
the pericardium and abdominal cavity3. However, mediastinal 
involvement has not been reported, neither as a part of the 
disseminated clinical form nor the isolated disease. Cryptococcus 
neoformans4, Rhodococcus equi5, and Streptococcus pneumoniae6 have 
been identified as causes of mediastinitis in HIV/AIDS patients. 
Pericardial involvement in MAC infection has been reported. 
Pericardial effusion in HIV/AIDS patients is generally related to 
opportunistic infections or malignancy, but frequently, the cause is 
not identified7. Sometimes, this cardiac complication might represent 
a medical emergency, mainly when cardiac tamponade occurs, 
and may be a marker of end-stage HIV infection8. Fortunately, the 
pericardial effusion in our patient was moderate and did not exhibit 
this level of cardiac complication. Mesenteric or retroperitoneal 
lymph node enlargement and hepatosplenomegaly are common 
during MAC infection in patients with HIV/AIDS2. Our patient 
presented with all of these features, resulting in a significant intestinal 
obstruction. The physiopathological mechanisms of DMAC disease 
could explain the clinical presentation of our patient. We suspect that 
the mediastinal lymph nodes developed necrosis and drained to the 
mediastinum, involving neighboring organs such as the pericardium 
and lungs, and shortly after, the necrosis extended over the chest wall 
and resulted in 2 skin abscesses.
M. tuberculosis and MAC, often presents with the same clinical 
features in severely immunodeficient HIV patients2,3. Considering 
that M. tuberculosis disease is a relevant public health problem in 
developing countries with a high incidence, the first presumptive 
diagnosis was tuberculosis before the identification of Mycobacterium 
species. The diagnosis of a DMAC infection is usually achieved 
through isolation from blood culture, and the species is identified 
rapidly by species-specific molecular probes. If blood cultures fail to 
grow the mycobacteria, lymph node, bone marrow, or liver biopsies 
are helpful to establish the diagnosis2. Then, after a favorable clinical 
response with anti-MAC therapy, repeated negative cultures for 
fungi and pyogenic microorganisms from overall samples, and PRA 
analysis, we concluded that our patient had a very rare manifestation 
of DMAC disease.
Highly active antiretrov iral  therapy (HA ART) and 
chemoprophylaxis have changed the natural course of MAC 
infection in patients with HIV/AIDS, with an important reduction 
of its incidence and survival improvement in patients with severe 
immunodeficiency3. However, patients without adequate adherence 
to HAART continue to be at risk for DMAC. In the present case, 
HAART plus specific MAC treatment showed some positive effects 
during the first few months, with the disappearance of mediastinitis, 
chest wall abscesses, and pericardial effusion. Thereafter, the patient’s 
condition worsened and he died. Therapeutic failure could be due to 
either a reduced adherence to therapy or possible MAC resistance. 
Nowadays, impaired tolerance to the multi-drug regiments against 
MAC microorganisms in patients with HIV/AIDS is usually due 
to gastrointestinal intolerance and drug toxicity, besides other 
concomitant drug regimens. MAC resistance has been reported in 
~13% of patients treated with long-term standard clarithromycin-
based regimens due to non-compliance with MAC therapy, with 
a median time to treatment failure of 7 months9. In addition, there 
appears to be impaired drug absorption of some of the oral drugs 
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